Lv7
5000 积分 2021-07-15 加入
Identification of potential biomarkers for the study of the mechanisms of immune thrombocytopenia using bioinformatics and metabolomics
8天前
已完结
Epigenetic programming defines haematopoietic stem cell fate restriction
8天前
已完结
Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia
23天前
已完结
SOHO State of the Art Updates and Next Questions | Latest Advances in the Management of Primary Mediastinal B-Cell Lymphoma
27天前
已关闭
A Real‐Life Multicenter Study of Checkpoint Inhibitors in Relapsed/Refractory Primary Mediastinal B‐Cell Lymphoma
27天前
已完结
Clinicopathologic Features and Genomic Signature of De Novo CD5+ Diffuse Large B-Cell Lymphoma
29天前
已完结
Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia
1个月前
已完结
Immune priming with avelumab and rituximab prior to R-CHOP in diffuse large B-cell lymphoma: the phase II AvR-CHOP study
1个月前
已完结
Comparative Study on the Clinicopathologic and Molecular Characteristics of Primary and Secondary Diffuse Large B-cell Lymphoma in the Central Nervous System
2个月前
已关闭
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
2个月前
已完结
皖公网安备34019202002308
